Back to Search
Start Over
Successful treatment of stage IVB ovarian carcinosarcoma with PARP Inhibitor: A case report.
- Source :
-
Gynecologic oncology reports [Gynecol Oncol Rep] 2024 Jan 03; Vol. 51, pp. 101322. Date of Electronic Publication: 2024 Jan 03 (Print Publication: 2024). - Publication Year :
- 2024
-
Abstract
- •Ovarian carcinosarcoma is a rare ovarian cancer histology that has limited treatment options.•In this study, we present an unusual association between carcinosarcoma and a STIC lesion.•In select patients with carcinosarcoma, PARP inhibition may provide clinical benefit.<br />Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.<br /> (© 2024 The Authors.)
Details
- Language :
- English
- ISSN :
- 2352-5789
- Volume :
- 51
- Database :
- MEDLINE
- Journal :
- Gynecologic oncology reports
- Publication Type :
- Academic Journal
- Accession number :
- 38273934
- Full Text :
- https://doi.org/10.1016/j.gore.2024.101322